Ausdal Financial Partners, Inc.

Position in MRNA — Moderna, Inc.

CIK 1667146 Davenport, IA

Position in MRNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$902,966

+$453,438 QoQ

Shares Held

12,894

+45.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#313

of 772 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ausdal Financial Partners, Inc. holds $2,218,484 across 8 Biotechnology names. MRNA ranks #1 (40.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc. This page	12,894	$902,966
2	VRTX	Vertex Pharmaceuticals Inc / Ma	854	$424,207
3	ARWR	Arrowhead Pharmaceuticals, Inc.	4,725	$385,134
4	TNGX	Tango Therapeutics, Inc.	8,991	$281,058
5	ABCL	AbCellera Biologics Inc.	15,167	$119,060
6	IMRX	Immuneering Corp	10,000	$49,900
7	MNKD	Mannkind Corp	10,507	$44,759
8	ONCY	Oncolytics Biotech Inc	12,000	$11,400

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$902,966	12,894	+45.7%	Shares	Sole	2026-08-14
2026-03-31	$449,528	8,849	+21.1%	Shares	Other	2026-05-12
2025-12-31	$215,541	7,309	+271.6%	Shares	Other	2026-02-13
2024-06-30	$233,581	1,967	+1.1%	Shares	Sole	2024-08-06
2023-06-30	$236,317	1,945	-14.5%	Shares	Sole	2023-07-31
2023-03-31	$349,394	2,275	+11.5%	Shares	Sole	2023-05-04
2022-12-31	$366,604	2,041	+21.9%	Shares	Sole	2023-02-03
2022-06-30	$239,273	1,675	+39.4%	Shares	Sole	2022-08-09
2022-03-31	$207,056	1,202	+13.4%	Shares	Sole	2022-05-04
2021-12-31	$269,218	1,060	+41.1%	Shares	Sole	2022-02-08
2021-09-30	$289,029	751	-52.0%	Shares	Sole	2021-11-01
2021-03-31	$204,805	1,564	-56.0%	Shares	Sole	2021-05-05
2020-12-31	$278,234	3,558	+7.4%	Shares	Sole	2021-02-01
2020-09-30	$234,465	3,314	—	Shares	Sole	2020-11-04
No filing history on record for this holder in this stock.